Navigation Links
Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.
Date:11/4/2008

SAN FRANCISCO, Nov. 4 /PRNewswire-FirstCall/ Medizone International, Inc. (Pink Sheets: MZEI) announces the establishment of a strategic consulting relationship with TDV Global, Inc. (TDVGlobal.com). TDV Global is a highly professional and experienced strategic management consulting firm. Approximately 70% of their business involves consulting for government agencies and projects, the remainder for private enterprise, mostly in the Health and Security Medical fields. TDV Global has assisted Medizone with the founding of its recently established non-profit affiliate, The Canadian Foundation for Global Health (CFGH). Mr. Brad Goble, the President of TDV Global, has been appointed an officer and member of the Board of Directors of the Canadian Foundation for Global Health. Additionally, the offices for the CFGH are being located at TDV Global in Ottawa. Working with Dr. Michael E. Shannon of Medizone International, TDV Global has also played a key role in producing the product development plan for Medizone's Hospital Sterilization Initiative.

Edwin Marshall, Chairman of the Board and CEO of Medizone commented, "Over the past ten years, Dr. Shannon has successfully worked on many different projects with Mr. Goble and his firm. Between the Hospital Sterilization Initiative and founding the CFGH, Medizone has been working with TDV Global since mid-September. I could not be more pleased with the results so far. Given their many current health related activities involving G-8 countries, TDV will assist Medizone in strategically aligning us with government and institutional interests in Canada, the US and Europe. We welcome TDV Global as a vital and strategic partner."

Medizone International, Inc., is a research and development stage company engaged in the development of patented and unpatented technologies and protocols for O3 based bio-oxidative treatment of diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B & C, and Herpes, the decontamination of blood, blood products and veterinarian serum products, and the treatment of external pathogenic conditions. It is currently developing technology to decontaminate and sterilize hospital surgical suites, emergency rooms and intensive care units.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

Web site: http://www.medizoneint.com

Investor Relations 800-953-3350


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009
2. Chindex International, Inc. Announces Appearances at Additional November Conferences
3. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
4. Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information
5. China Yingxia International, Inc. to Promote Benefits of Its Soy Milk Products Over Scandal-Stricken Cows Milk in China
6. Block Imaging International, Inc. Partners with Dicom Solutions, Inc. to Offer New Products
7. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
8. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
9. WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air
10. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
11. Chindex International, Inc. Announces CDC Contract Signing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
Breaking Medicine Technology: